Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients - Full Text View

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

This study has been completed.

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00069719

Purpose

To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.

Condition	Intervention	Phase
Open-Angle Glaucoma Ocular Hypertension	Drug: Glaucoma therapy	Phase II

Genetics Home Reference related topics:

early-onset glaucoma

MedlinePlus related topics:

Glaucoma High Blood Pressure

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Official Title:	Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Further study details as provided by Alcon Research:

Study Start Date:	February 1999
Study Completion Date:	August 2003
Primary Completion Date:	August 2003 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
logMAR visual acuity not worse than 0.6.

Exclusion Criteria:

Clinically relevant ophthalmic or systemic conditions may be excluded.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00069719

Locations


United States, Texas
	Alcon Clinical Trial Sites
	Multiple Locations Throughout the US Sponsored by Alcon of, Texas, United States

Sponsors and Collaborators

Alcon Research

More Information

Study ID Numbers:	C-02-33, C-02-33
First Received:	September 30, 2003
Last Updated:	August 4, 2008
ClinicalTrials.gov Identifier:	NCT00069719
Health Authority:	United States: Food and Drug Administration

Keywords provided by Alcon Research:

open-angle

glaucoma

ocular

hypertension

POAG

Study placed in the following topic categories:

Glaucoma

Eye Diseases

Glaucoma, Open-Angle

Vascular Diseases

Hypertension

Ocular Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on November 20, 2008